TB-500 (Thymosin Beta-4)
TB-500 (Thymosin Beta-4). Synthetic thymosin fragment for tissue repair.
How it works. Sequesters G-actin, promotes angiogenesis and cell migration.
What the research supports. 1 graded claims. Strongest: Accelerates wound healing (moderate).
How much to take. Typical dose: 2 mg subcutaneous twice weekly.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Collagen peptides, Vitamin C.
Common forms. Available as Subcutaneous injection, Oral or sublingual lozenge, Nasal spray, Compounded topical.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried TB-500 (Thymosin Beta-4). Anecdotes are not medical advice.
TB-500 (Thymosin Beta-4). Synthetic thymosin fragment for tissue repair.
What it is
Synthetic thymosin fragment for tissue repair.
Food sources
Goals
How it works
Sequesters G-actin, promotes angiogenesis and cell migration.
Pathways
- Sequesters G-actin, promotes angiogenesis
- cell migration
Effects
- +Accelerates wound healing supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Injection site pain
Medication interactions
Always disclose TB-500 (Thymosin Beta-4) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Collagen peptidesProvides amino acid substrate for connective tissue synthesis.
- Vitamin CRequired cofactor for collagen hydroxylation.
Common forms
- Subcutaneous injection
- Oral or sublingual lozenge
- Nasal spray
- Compounded topical
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "Accelerates wound healing". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching TB-500 (Thymosin Beta-4) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…